Year: 2015
Type: review
Abstract: Apolipoprotein E (APOE) is a lipid-transport protein abundantly expressed in most neurons in the central nervous system. APOE-dependent alterations of the endocytic pathway can affect different functions. APOE binds to cell-surface receptors to deliver lipids and to the hydrophobic amyloid-β peptide, regulating amyloid-β aggregations and clearances in the brain. Several APOE isoforms with major structural differences were discovered and shown to influence the brain lipid transport, glucose metabolism, neuronal signaling, neuroinflammation, and mitochondrial function. This review will summarize the updated research progress on APOE functions and its role in Alzheimer's disease, Parkinson's disease, cardiovascular diseases, multiple sclerosis, type 2 diabetes mellitus, Type III hyperlipoproteinemia, vascular dementia, and ischemic stroke. Understanding the mutations in APOE, their structural properties, and their isoforms is important to determine its role in various diseases and to advance the development of therapeutic strategies. Targeting APOE may be a potential approach for diagnosis, risk assessment, prevention, and treatment of various neurodegenerative and cardiovascular diseases in humans.
DOI: 10.2147/ndt.s84266
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: apolipoprotein E, APOE isoforms, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, multiple sclerosis, type 2 diabetes, type III hyperlipoproteinemia, vascular dementia, ischemic stroke, cardiovascular disease, amyloid-beta clearance, lipid transport, neuroinflammation, mitochondrial function, glucose metabolism, therapeutic targeting
Open Access status: gold
Estimated APC paid: $2,836
Award: G1724560180
OpenAlex ID: W1606053795
